• / Free eNewsletters & Magazine
  • / My Account
Home>Ligand Partner Spectrum Pharmaceuticals Announces Submission of New Drug Application for Captisol-Enabled™ Melphalan

Ligand Partner Spectrum Pharmaceuticals Announces Submission of New Drug Application for Captisol-Enabled™ Melphalan

3party Content

Fri, 26 Dec 2014

Ligand Partner Spectrum Pharmaceuticals Announces Submission of New Drug Application for Captisol-Enabledâ„¢ Melphalan
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.